Publication | Closed Access
Phase III, Randomized, Double-blind Trial of Sunitinib Versus Placebo in Patients With Progressive, Well-differentiated Pancreatic Islet Cell Tumours
11
Citations
0
References
2009
Year
Pancreatic CancerSunitinib Versus PlaceboMedicinePhase IiiPharmacologyDouble-blind TrialPathologyCancer TreatmentOncologyRadiation OncologyCancer Research
No additional data available for this publication yet. Check back later!